118 related articles for article (PubMed ID: 14572344)
1. [Influence of interferon alpha on the serum fibrosis markers of chronic hepatitis C patients].
Zhang BB; Zhu SH; Cai WM
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):622-3. PubMed ID: 14572344
[No Abstract] [Full Text] [Related]
2. [Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha].
Deng L; Zhou Y; Peng X; Deng H; Deng Y; Yao J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():66-7. PubMed ID: 11509145
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of the therapeutic effect of interferon-alpha on liver fibrosis].
Huang Y; Wang C; Li S; Zhou M
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):71. PubMed ID: 11856515
[No Abstract] [Full Text] [Related]
4. Serum surrogate markers of liver fibrosis in primary biliary cirrhosis.
Voumvouraki A; Koulentaki M; Notas G; Sfakianaki O; Kouroumalis E
Eur J Intern Med; 2011 Feb; 22(1):77-83. PubMed ID: 21238899
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].
Iushchuk ND; Znoĭko OO; Safiullina NKh; Dudina KR; Kelli EI; Klimova EA; Kashirin VI; Braginskiĭ DM; Kushlinskiĭ NE; Liubimova NV; Vasilev AIu; Penkina TV; Danilin AG
Ter Arkh; 2005; 77(4):50-5. PubMed ID: 15938533
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effect of alpha 1b interferon on patients with chronic hepatitis B: changes in serological fibrosis markers and histology].
Zhang HY; Lu H; Li XM; Duan HY
Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):117-8. PubMed ID: 12648417
[No Abstract] [Full Text] [Related]
8. [Anti-fibrosis effect of IFN-gamma and IFN-alpha on chronic hepatitis B patients].
Li XH; Wang CG; Pan XN; Li YX; Zhuang YP
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):243. PubMed ID: 12716531
[No Abstract] [Full Text] [Related]
9. Long-term follow-up of interferon-treated chronic hepatitis C and serum hepatic fibrosis markers.
Ueno T; Ide T; Hashimoto O; Uchimura Y; Torimura T; Kumashiro R; Inuzuka S; Sata M
Hepatogastroenterology; 2001; 48(40):1124-8. PubMed ID: 11490815
[TBL] [Abstract][Full Text] [Related]
10. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
Xu GG; Luo CY; Wu SM; Wang CL
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
[TBL] [Abstract][Full Text] [Related]
11. [Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis].
Liang XH; Zheng H
Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):67-8. PubMed ID: 12575242
[TBL] [Abstract][Full Text] [Related]
12. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
Zheng M; Cai W; Weng H; Liu R
Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
[TBL] [Abstract][Full Text] [Related]
13. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
[TBL] [Abstract][Full Text] [Related]
15. [Measurement of serum marks of hepatic fibrosis and portal pressure for the diagnosis of early hepatic fibrosis].
He J; Liu C; Chen M; Yang P; Song X; Wang H
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):67. PubMed ID: 11856511
[No Abstract] [Full Text] [Related]
16. Non-invasive diagnostic screening of hepatic fibrosis in patients with chronic hepatitis B.
Chen YP; Feng XR; Dai L; Zhang L; Hou JL
Chin Med J (Engl); 2004 Jul; 117(7):1109-12. PubMed ID: 15265393
[No Abstract] [Full Text] [Related]
17. [Clinical and pathological study on liver fibrosis in viral hepatitis].
Xin S; Mao Y; Wang L; Li Y; Li L; Yu H; Zhao M; Zhang S; Wang S; Wang X; Chen L; Zhou X; Zhou Y; Zou Z; Tang S; Huangpu Y; Zhang L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):240-3. PubMed ID: 15617338
[TBL] [Abstract][Full Text] [Related]
18. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
19. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
[TBL] [Abstract][Full Text] [Related]
20. Long-term histological prognosis and serum fibrosis markers in chronic hepatitis C patients treated with interferon.
Kojima H; Hongo Y; Harada H; Inoue T; Miyaji K; Kashiwagi M; Momose T; Arisaka Y; Fukui H; Murai S; Tokita H; Kamitsukasa H; Yagura M; Katsu K
J Gastroenterol Hepatol; 2001 Sep; 16(9):1015-21. PubMed ID: 11595066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
